Cell Culture Technology– category –
-
BioPharm International Emphasizes Standardization and Automation for Overcoming Complex Cell & Gene Therapy Manufacturing Challenges
BioPharm International USA Overview BioPharm International highlighted that standardization and automation are critical for navigating the complex landscape of cell and gene therapy (CGT) manufacturing. To improve global patient access t... -
Regulatory Complexity Poses Market Challenges for Cultivated Meat Products: US USDA Approval Amidst Inconsistent State Regulations
PetfoodIndustry USA Overview Regulatory complexity for cell-cultivated meat products poses significant challenges for manufacturers in consumer engagement. While the USDA approved cell-cultivated chicken sales in 2023 and established a r... -
Process Analytical Technology (PAT) Revolutionizes Biopharmaceutical Manufacturing with Real-Time Bioreactor Monitoring
Technology Networks USA Overview The biopharmaceutical industry is rapidly adopting Process Analytical Technology (PAT), including Raman and Near-Infrared (NIR) spectroscopy, for real-time bioreactor monitoring, significantly enhancing p... -
BioProcess International Advocates for Building a Distributed Model for Future Autologous Cell Therapy Manufacturing
BioProcess International Netherlands Overview BioProcess International and IB Communications held a video roundtable proposing the construction of a distributed manufacturing model for the future of autologous cell therapy biomanufacturi... -
CCRM, OmniaBio, and Avectas Partner to Enhance Cell Therapy Manufacturing with Automated Platform Evaluation
BioSpace Canada Overview CCRM and its CDMO subsidiary, OmniaBio Inc., have partnered with Avectas Limited to evaluate an automated, integrated, and scalable cell therapy manufacturing platform. This collaboration aims to explore how Avec... -
Orca Bio Boosts East Coast Manufacturing Capacity, Triples West Coast Workforce Ahead of Potential Orca-T® Launch
BioSpace USA Overview Orca Bio announced the expansion of its East Coast manufacturing capacity and a threefold increase in its West Coast manufacturing workforce, in anticipation of the potential launch of its flagship program, Orca-T®.... -
Distek Unveils BIOne Core Software: A Cloud-Based SaaS Solution for Streamlined Bioprocess Historical Data Management
Labcompare.com USA Overview Distek has launched 'BIOne Core Software,' a cloud-based historical data software platform designed exclusively for BIOne Bioprocess Controllers, offered as a SaaS solution. This software enables users to easi... -
NTHRYS Accelerates Bioprocess Development with AI-Powered DoE Automation: Integrating Media Optimization, Scale-Up, and IoT Parameter Control
NTHRYS India Overview NTHRYS Biotech Labs is accelerating bioprocess development through AI-powered Design of Experiments (DoE) automation solutions. These include machine learning tools for predicting optimal media composition and autom... -
BioProcess International Reports on Mesenchymal Stem Cell (MSC) Large-Volume Manufacturing Challenges and Corning HYPERStack™ Contribution
BioProcess International USA Overview BioProcess International reported on the challenges and progress in large-volume manufacturing of mesenchymal stem cells (MSCs). The approval of two iPSC-derived therapies in Japan indicates growing ... -
New Market Pitch Evaluates Top Cell Therapy Startups Including Orca Bio, Cellares, and Kelonia: Differentiated by Clinical, Manufacturing, and Strategic Advancements
New Market Pitch USA Overview New Market Pitch selected ten leading cell therapy startups—Orca Bio, Kyverna, Cabaletta Bio, Cellares, Immatics, Iovance, Sana, Kelonia, Orna, and Dispatch Bio—evaluating their regulatory maturity, clinical...
